EntrepreneurialCheck
David de Gruijl estimated net worth profile

David de Gruijl net worth

David de Gruijl Net Worth 2026 (Estimated) · Founder at Anto Biosciences · YC F25
est. wealth $10.0M

Quick answer

David de Gruijl's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. David de Gruijl is Founder at Anto Biosciences. Anto Biosciences valuation.

David de Gruijl is Founder at Anto Biosciences (YC F25). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameDavid de Gruijl
RoleFounder
CompanyAnto Biosciences
YC batchF25
Est. company val$20.0M
Assumed ownership50%
Est. paper wealth / net worth$10.0M
$7.0M – $15.0M
  • Company status: Active
  • Region: United States of America
  • Industries: Healthcare
  • Team size: 4
  • Website: https://www.anto.bio/

Who is David de Gruijl?

David de Gruijl is a founder at Anto Biosciences, which participated in Y Combinator's 2025 batch.

Highlights:

  • Y Combinator F25
  • Anto Biosciences

About Anto Biosciences

Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures.

Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed...

FAQ: David de Gruijl net worth and Anto Biosciences valuation

What is David de Gruijl's net worth?

David de Gruijl's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. David de Gruijl is Founder at Anto Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Anto Biosciences valuation?

Anto Biosciences's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is David de Gruijl's role?

David de Gruijl is Founder at Anto Biosciences, a Y Combinator-backed startup (batch F25).